Spark Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-34,500
| Closed | -$164K | – | 54 |
|
|
2020
Q2 | $164K | Sell |
34,500
-338,200
| -91% | -$1.61M | 0.6% | 39 |
|
|
2020
Q1 | $745K | Buy |
372,700
+180,221
| +94% | +$360K | 0.4% | 85 |
|
|
2019
Q4 | $664K | Sell |
192,479
-999
| -0.5% | -$3.45K | 0.08% | 307 |
|
|
2019
Q3 | $554K | Buy |
193,478
+111,078
| +135% | +$318K | 0.07% | 241 |
|
|
2019
Q2 | $312K | Buy |
82,400
+34,200
| +71% | +$129K | 0.02% | 415 |
|
|
2019
Q1 | $392K | Buy |
+48,200
| New | +$392K | 0.02% | 426 |
|
|
2018
Q3 | – | Sell |
-60,200
| Closed | -$344K | – | 668 |
|
|
2018
Q2 | $344K | Buy |
+60,200
| New | +$344K | 0.02% | 487 |
|
|
2016
Q3 | – | Sell |
-181,800
| Closed | -$516K | – | 828 |
|
|
2016
Q2 | $516K | Sell |
181,800
-348,300
| -66% | -$989K | 0.05% | 457 |
|
|
2016
Q1 | $1.5M | Buy |
530,100
+442,500
| +505% | +$1.25M | 0.15% | 217 |
|
|
2015
Q4 | $904K | Buy |
+87,600
| New | +$904K | 0.12% | 260 |
|
|
2014
Q4 | – | Sell |
-78,300
| Closed | -$764K | – | 697 |
|
|
2014
Q3 | $764K | Sell |
78,300
-33,600
| -30% | -$328K | 0.11% | 259 |
|
|
2014
Q2 | $1.43M | Buy |
111,900
+58,800
| +111% | +$749K | 0.21% | 166 |
|
|
2014
Q1 | $561K | Buy |
+53,100
| New | +$561K | 0.09% | 325 |
|